Applied Therapeutics Inc (APLT)
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Shoshana Shendelman |
| Employees: | 30 |
| Web site: | www.appliedtherapeutics.com |
| 545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY, 10017 212-220-9226 | |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosmia in healthy volunteers and adults. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for treatment of diabetic peripheral neuropathy.
Please log in first to see chart